Attendo AB (publ) (STO:ATT)
Sweden
· Delayed Price · Currency is SEK 63.10
+1.10 (1.77%)
Apr 25, 2025, 5:29 PM CET
Attendo AB Revenue
In the year 2024, Attendo AB had annual revenue of 18.98B SEK with 9.79% growth. Attendo AB had revenue of 4.88B in the quarter ending December 31, 2024, with 10.31% growth.
Revenue
18.98B
Revenue Growth
+9.79%
P/S Ratio
0.50
Revenue / Employee
575.15K
Employees
33,000
Market Cap
9.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.98B | 1.69B | 9.79% |
| Dec 31, 2023 | 17.29B | 2.79B | 19.25% |
| Dec 31, 2022 | 14.50B | 1.63B | 12.66% |
| Dec 31, 2021 | 12.87B | 579.00M | 4.71% |
| Dec 31, 2020 | 12.29B | 353.00M | 2.96% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Bonesupport Holding AB | 898.73M |
| Vitrolife AB | 3.61B |
| AddLife AB | 10.42B |